Latest news with #FujifilmHoldings
Nikkei Asia
3 days ago
- Business
- Nikkei Asia
Japan's Fujifilm, others invest in domestic antibiotics supply chain
Japanese pharmaceutical companies are investing in new facilities to produce the base ingredients used to make antibiotics. (Photo by Akitoshi Sugiura) KOHEI YAMADA TOKYO -- Japanese pharmaceutical companies are ramping up investment to build a domestic supply chain for antibiotics, fueled by government subsidies designed to reduce the nation's reliance on China for critical medicines. Fujifilm Toyama Chemical, a subsidiary of Fujifilm Holdings, will invest about 10 billion yen ($67.3 million) to expand its plant in the city of Toyama. By 2028, the company plans to begin mass producing ampicillin hydrate, an active pharmaceutical ingredient (APIs) essential to the production of penicillin-based antibiotics, and to step up production of other APIs.
Nikkei Asia
11-06-2025
- Business
- Nikkei Asia
Canon, Fujifilm face GE HealthCare's growing scope
TOKYO -- U.S.-based GE HealthCare Technologies has expanded its reach in Japan while wielding market-leading computed tomography (CT) scanners as well as diagnostic drugs, pushing local players Canon and Fujifilm Holdings to try to counter its substantially larger scale. GE HealthCare entered the field of surgical treatment with an acquisition in 2021 and was spun off from General Electric in January 2023. The company looks to expand further through the highly profitable diagnostic drug business -- radiopharmaceuticals in particular. Radioactive substances can be used to diagnose cancer and Alzheimer's disease as well as aid in providing treatment tailored to each patient.
.JPG%3Fwidth%3D1260%26fit%3Dcover%26gravity%3Dfaces%26dpr%3D2%26quality%3Dmedium%26source%3Dnar-cms%26format%3Dauto%26height%3D630&w=3840&q=100)
Nikkei Asia
06-05-2025
- Business
- Nikkei Asia
Fujifilm to tap India's growing chip industry with new materials plant
TOKYO -- Fujifilm Holdings will build a semiconductor materials factory in India to supply a chip project backed by the country's government, hoping to tap into a supply chain that is growing as high-tech production moves away from China. The Japanese company will acquire land for the plant in the western state of Gujarat this year and start construction as early as 2026. Fujifilm aims to have it operating around 2028.
Nikkei Asia
22-04-2025
- Business
- Nikkei Asia
Japan's Fujifilm rides US-China rift to land $3bn biopharma deal
TOKYO -- Fujifilm Holdings announced on Tuesday that it has signed a contract worth more than $3 billion to manufacture biologic drugs in the U.S. for a major American pharmaceutical company. The 10-year deal with Regeneron Pharmaceuticals, which marks the largest publicly known manufacturing contract for biopharmaceuticals on record, comes as U.S. pharmaceutical companies are doubling down on domestic supply in response to economic security policies and tariff measures by U.S. President Donald Trump.
